EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
Clinical trial NCT02305797 · COMPLETED
Trial details
- NCT number
- NCT02305797
- Sponsor
- Edgemont Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2016-05-01
- Enrollment
- 495
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.